Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559078 · ClinicalTrials.gov registry record
Qualitative Research on Women With Congenital Adrenal Hyperplasia
A clinical trial, sponsored by Lehigh University.
- Completed
- Registry status
- 16
- Enrollment target
NCT00559078: Completed study, sponsored by Lehigh University.
NCT00559078 is a clinical trial that has completed, run by Lehigh University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00559078 has completed, sponsored by Lehigh University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This qualitative interview-based study will investigate the impact that living with congenital adrenal hyperplasia has for women in the following areas: health-related quality of life (HRQL), psychological health, and health-seeking behaviors.
Interventions
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-05 |
What the finished NCT00559078 record still lists
NCT00559078 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.
NCT00559078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00559078 about?
NCT00559078 is a clinical study titled "Qualitative Research on Women With Congenital Adrenal Hyperplasia". This qualitative interview-based study will investigate the impact that living with congenital adrenal hyperplasia has for women in the following areas: health-related quality of life (HRQL), psychological health, and health-seeking behaviors.
What is the current status of trial NCT00559078?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2007-07. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00559078?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT00559078?
This trial is sponsored by Lehigh University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia